Carregant...
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study
Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial...
Guardat en:
| Publicat a: | Asian J Androl |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5507085/ https://ncbi.nlm.nih.gov/pubmed/27232853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.179528 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|